A Study of JZP150 in Adults With Posttraumatic Stress Disorder
Study sponsor: Jazz Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12-05Actual
Enrollment · participants282Actual
Source updated2024-12-31Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.